A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes and obesity that are already taking metformin. The study will last for about 89 weeks.
Epistemonikos ID: 3f6350d29f0f6a6840cd5d10bf3807bb2b963fcb
First added on: May 15, 2024